Analyst Ratings for Idenix Pharmaceuticals Inc. (IDIX) [Buys]
IDIX Rating Summary
IDIX Price Target Summary
- Highest: $14.00 (William Blair)
- Lowest: $5.00 (Maxim Group)
- Average: $8.44
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$8.44 (+95.9%)
Avg. $ Target:
$8.44 (+95.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/28/2012 | Deutsche Bank | New Coverage | Buy (N/A) |
7.00 (N/A) |
4.52 | 4.31 | -4.65% | Details |
| 7/20/2012 | UBS » Updated 5/3/2013 |
New Coverage | Buy (N/A) |
7.00 (8.00) |
10.15 | 4.31 | -57.54% | Details |
| 11/29/2011 | William Blair » Updated 2/3/2012 |
Upgrade | Outperform (N/A) |
14.00 (N/A) |
7.10 | 4.31 | -39.3% | Details |
| 7/25/2011 | JPMorgan | New Coverage | Overweight (N/A) |
12.00 (N/A) |
6.34 | 4.31 | -32.02% | Details |
| 10/27/2010 | Gleacher & Co. | New Coverage | Buy (N/A) |
N/A (N/A) |
4.50 | 4.31 | -4.22% | Details |
